Survival advantage of exemestane (EXE, Aromasin®) over...

Survival advantage of exemestane (EXE, Aromasin®) over megestrol acetate (MA) in postmenopausal women with advanced breast cancer (ABC) refractory to tamoxifen (TAM): results of a phase III randomized double-blind study

E. Bajetta, L.Y. Dirix, L.E. Fein, S.E. Jones, J. Cervek, M. Kaufmann, C. Fowst, A. Polli, E. di Salle, G. Massimini
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Year:
1999
Language:
english
DOI:
10.1016/s0959-8049(99)80705-9
File:
PDF, 110 KB
english, 1999
Conversion to is in progress
Conversion to is failed